Fig. 3From: Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancerAssociation between positive ERCC1 staining and 10q23 (PTEN), 5q21 (CHD1), 6q15 (MAP3K7), and 3p13 (FOXP1) deletion in a) all cancers, b) the ERG-negative and c) ERG-positive subsetBack to article page